LFSC:NSD-F/m Emerald Life Sciences Innovation ETF (USD)

ETF | Others |

Last Closing

USD 25.614

Change

+0.13 (+0.50)%

Market Cap

USD 0.06B

Volume

2.40K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+1.05 (+1.94%)

USD 59.02B
QQQM Invesco NASDAQ 100 ETF

+0.14 (+0.06%)

USD 42.88B
JEPQ JPMorgan Nasdaq Equity Premium..

N/A

USD 22.89B
ACWI iShares MSCI ACWI ETF

-0.11 (-0.09%)

USD 19.52B
CGABL The Carlyle Group Inc. 4.625% ..

-0.15 (-0.84%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-1.57 (-2.64%)

USD 4.90B
TBIL Rbb Fund Inc - Us Treasury 3 M..

-0.01 (-0.02%)

USD 4.81B
TSLL Direxion Shares ETF Trust - Di..

+0.81 (+4.67%)

USD 4.32B
ETHA iShares Ethereum Trust ETF

+0.65 (+3.31%)

USD 3.75B
USCL iShares Climate Conscious & Tr..

-0.21 (-0.28%)

USD 2.37B

ETFs Containing LFSC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.50% 88% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.50% 88% B+ 79% B-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.06B 60% D- 30% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike